The study suggests that making smoking cessation a priority and finding effective ways to help people with HIV quit can significantly improve their lifespan.
"Now that HIV-specific medicines are so effective against the virus itself, we also need to add other interventions that could improve and extend the lives of people with HIV," said Krishna P Reddy, of Massachusetts General Hospital and Harvard Medical School.
Smoking is especially dangerous for people living with HIV, putting them at high risk for heart disease, cancer, serious lung diseases and other infections.
For men and women with HIV who adhere well to HIV medicines, the study found that smoking reduces life expectancy by about twice as much as HIV.
The study also accounts for higher rates of non-adherence to HIV drug regimens and lower retention in care, making the latest findings especially relevant for health care providers and patients in this country.
Even when accounting for typical rates of treatment non-adherence and missed follow-up care, the study found that for men with HIV, the life expectancy loss associated with smoking was similar to that from HIV.
"We actually quantify the risk, and I think providing those numbers to patients can help put their own risks from smoking in perspective," he said.
"A person with HIV who consistently takes HIV medicines but smokes is much more likely to die of a smoking-related disease than of HIV itself," he added.
For example, men and women entering care for HIV at age 40 who continued to smoke lost 6.7 and 6.3 years of life expectancy, respectively, compared with people with HIV who never smoked, according to the modelling study.
"We show that even people who have been smoking till age 60 but quit at age 60 have a substantial increase in their life expectancy compared to those who continue to smoke," Reddy said.
The findings suggest that smoking cessation should be a major focus of health providers who care for people living with HIV and incorporated into existing care programs and treatment guidelines, researchers said.
The study was published in The Journal of Infectious Diseases.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
